Rodriguez-Antona C - Search Results

1

PBRM1 and KDM5C cooperate to define high-angiogenesis tumors and increased antiangiogenic response in renal cancer.

Santos M, Lanillos J, Caleiras E, Valdivia C, Roldan-Romero JM, Laínez N, Puente J, Beuselinck B, Oudard S, Zucman-Rossi J, Navarro P, Robledo M, Castellano D, de Velasco G, García-Donas J, Rodriguez-Antona C. Santos M, et al. Among authors: rodriguez antona c. Am J Cancer Res. 2023 May 15;13(5):2116-2125. eCollection 2023. Am J Cancer Res. 2023. PMID: 37293154 Free PMC article.

2

Human genetics: international projects and personalized medicine.

Apellaniz-Ruiz M, Gallego C, Ruiz-Pinto S, Carracedo A, Rodríguez-Antona C. Apellaniz-Ruiz M, et al. Drug Metab Pers Ther. 2016 Mar;31(1):3-8. doi: 10.1515/dmpt-2015-0032. Drug Metab Pers Ther. 2016. PMID: 26581075 Free article. Review.

3

Phenotype-genotype variability in the human CYP3A locus as assessed by the probe drug quinine and analyses of variant CYP3A4 alleles.

Rodríguez-Antona C, Sayi JG, Gustafsson LL, Bertilsson L, Ingelman-Sundberg M. Rodríguez-Antona C, et al. Biochem Biophys Res Commun. 2005 Dec 9;338(1):299-305. doi: 10.1016/j.bbrc.2005.09.020. Epub 2005 Sep 13. Biochem Biophys Res Commun. 2005. PMID: 16171783

4

Identification and phenotype characterization of two CYP3A haplotypes causing different enzymatic capacity in fetal livers.

Rodríguez-Antona C, Jande M, Rane A, Ingelman-Sundberg M. Rodríguez-Antona C, et al. Clin Pharmacol Ther. 2005 Apr;77(4):259-70. doi: 10.1016/j.clpt.2004.11.003. Clin Pharmacol Ther. 2005. PMID: 15903124

5

Transcriptional regulation of the human CYP2A6 gene.

Pitarque M, Rodríguez-Antona C, Oscarson M, Ingelman-Sundberg M. Pitarque M, et al. J Pharmacol Exp Ther. 2005 May;313(2):814-22. doi: 10.1124/jpet.104.081570. Epub 2005 Jan 25. J Pharmacol Exp Ther. 2005. PMID: 15671201

6

Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells.

Rodríguez-Antona C, Donato MT, Boobis A, Edwards RJ, Watts PS, Castell JV, Gómez-Lechón MJ. Rodríguez-Antona C, et al. Xenobiotica. 2002 Jun;32(6):505-20. doi: 10.1080/00498250210128675. Xenobiotica. 2002. PMID: 12160483

7

Novel aspects of drug metabolism and transport.

Afzelius L, Ingelman-Sundberg M, Karlgren M, Rodriguez-Antona C. Afzelius L, et al. Drug News Perspect. 2006 Dec;19(10):637-51. Drug News Perspect. 2006. PMID: 17299607

8

A novel polymorphic cytochrome P450 formed by splicing of CYP3A7 and the pseudogene CYP3AP1.

Rodriguez-Antona C, Axelson M, Otter C, Rane A, Ingelman-Sundberg M. Rodriguez-Antona C, et al. J Biol Chem. 2005 Aug 5;280(31):28324-31. doi: 10.1074/jbc.M502309200. Epub 2005 Jun 2. J Biol Chem. 2005. PMID: 15937338 Free article.

9

Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapy.

Ingelman-Sundberg M, Rodriguez-Antona C. Ingelman-Sundberg M, et al. Philos Trans R Soc Lond B Biol Sci. 2005 Aug 29;360(1460):1563-70. doi: 10.1098/rstb.2005.1685. Philos Trans R Soc Lond B Biol Sci. 2005. PMID: 16096104 Free PMC article. Review.

10

The hematopoietic-specific beta1-tubulin is naturally resistant to 2-methoxyestradiol and protects patients from drug-induced myelosuppression.

Escuin D, Burke PA, McMahon-Tobin G, Hembrough T, Wang Y, Alcaraz AA, Leandro-García LJ, Rodríguez-Antona C, Snyder JP, Lavallee TM, Giannakakou P. Escuin D, et al. Cell Cycle. 2009 Dec;8(23):3914-24. doi: 10.4161/cc.8.23.10105. Epub 2009 Dec 16. Cell Cycle. 2009. PMID: 19901556

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters